Invitae Corporation
NVTA
Ранг среди акций
#35702
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Цена акции
$0.016
Последняя синхронизация: 2024-03-11
Рыночная капитализация
$3.27M
Изменение (1 день)
-5.33%
Изменение (1 год)
5,233.33%
Страна
US
Торговля Invitae Corporation (NVTA)
Категория
Healthcare
История цены акций Invitae Corporation (NVTA)
Наивысшая цена закрытия: $0.00 2024-08-01
Наименьшая цена закрытия: $19.17 2015-02-01
Наименьшая цена закрытия: $19.17 2015-02-01
История цены акций Invitae Corporation с 2015 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2024 | -99.95% |
| 2023 | -71.56% |
| 2022 | -86.50% |
| 2021 | -67.85% |
| 2020 | 194.07% |
| 2019 | 47.18% |
| 2018 | 31.94% |
| 2017 | 20.96% |
| 2016 | -6.63% |
| 2015 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $676.04 | 19.19% |
US
|
|
| $229.53 | 5.24% |
US
|
|
| $388.44 | 106.59% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $171.89 | 17.84% |
US
|
